Previous 10 | Next 10 |
2024-01-18 20:48:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2023-12-08 08:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2023-12-01 13:00:48 ET Summary Fulgent Genetics, Inc. is a diagnostic company that is currently navigating through a significant decline in revenues as the pandemic ends. However, its "core" business is growing nicely, and the stock trades for just under the net cash on its balanc...
2023-11-25 09:45:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips If you’re searching for digital health stocks to add to your portfolio, look no further. Technological innovation is leading to the increased digitalization and personalization of health...
Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “Company”), a technology-based company with a well-established clinical diagnostic business and a therapeutic development business, today announced that members of its management team are scheduled to participate ...
Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “Company”), a technology-based company with a well-established clinical diagnostic business and a therapeutic development business, today announced data from two poster presentations being presented tomorrow, Nove...
2023-11-03 12:22:15 ET Fulgent Genetics, Inc. (FLGT) Q3 2023 Earnings Call Transcript November 03, 2023, 08:30 AM ET Company Participants Melanie Solomon - IR Ming Hsieh - CEO Brandon Perthuis - CCO Paul Kim - CFO Lawrence Weiss - Chief Medical Officer ...
2023-11-03 07:08:46 ET More on Fulgent Genetics Fulgent Genetics: Navigating Post-COVID Growing Pains Fulgent Genetics Q3 2023 Earnings Preview Seeking Alpha’s Quant Rating on Fulgent Genetics Historical earnings data for Fulgent Genetics Finan...
HST Global Inc (HSTC) is expected to report for quarter end 2023-09-30 Air China Ltd ADR - Level I (AIRYY) is expected to report for Q3 2023 GrafTech International Ltd. (EAF) is expected to report $-0.05 for Q3 2023 Cardinal Health Inc. (CAH) is expected to report $1.4 for Q1 2024 ...
Core Revenue of $66 million represents Growth of 17% Year-over-Year Additional Reimbursement from COVID-19 Test Sales yields Revenue of $19 million, for Total Revenue of $85 million Reiterates Full Year 2023 Core Revenue Guidance of $260 million Fulgent Genetics, Inc. (NASDAQ: F...
News, Short Squeeze, Breakout and More Instantly...
Fulgent Genetics Inc. Company Name:
FLGT Stock Symbol:
NASDAQ Market:
Fulgent Genetics Inc. Website:
Commercial National Financial Corp. (CNAF) is expected to report for Q1 2024 First National Bank Alaska (FBAK) is expected to report for Q1 2024 Cyxtera Technologies Inc. (CYXTQ) is expected to report for quarter end 2024-03-31 Brookfield Renewable Corporation Class A Subordinate (BEP...
Total Revenue of $64.5 million Core Revenue grows 1% year-over-year to $63.2 million Reiterates Full Year 2024 Core Revenue Guidance of $280 million Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent,” or the “Company”), a technology-based company with a...